Unclaimed
Phillip R. Musich
Is this your partnering profile? Claim & update it for free.
This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
About
Phillip R. Musich studies intracellular signaling and trafficking that govern cell survival, stress responses, and therapeutic resistance. His work spans engineered T-cell therapies, extracellular vesicle delivery, and signaling pathway modulation (EMT/EndMT) across oncology and cardiovascular disease.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
Journal of Translational Medicine
•2025
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Journal of Translational Medicine
•2023
The application of exosomes in the treatment of triple-negative breast cancer
Frontiers in Molecular Biosciences
•2022
Prolyl Isomerization-Mediated Conformational Changes Define ATR Subcellular Compartment-Specific Functions
Frontiers in Cell and Developmental Biology
•2022
Wnt2 Contributes to the Development of Atherosclerosis
Frontiers in Cardiovascular Medicine
•2021
The Contribution of Endothelial-Mesenchymal Transition to Atherosclerosis
International Journal of Translational Medicine
•2021
Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter?
Neuro-Oncology Advances
•2021
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
Journal of Translational Medicine
•2020
The role of disabled-2 (Dab2) in diseases
2020
DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
Frontiers in Pharmacology
•2020
PP2A Regulates Phosphorylation-Dependent Isomerization of Cytoplasmic and Mitochondrial-Associated ATR by Pin1 in DNA Damage Responses
Frontiers in Cell and Developmental Biology
•2020
Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR’s Anti-apoptotic Function at Mitochondria, and the Implications in Cancer
Frontiers in Cell and Developmental Biology
•2020
No funding yet
This innovator hasn't added funding yet. In the meantime, you might want to explore their publications, patents, and other profile details.
No patents yet
This innovator hasn't added patents yet. In the meantime, you might want to explore their publications, funding, and other profile details.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.